XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Sales:        
Total sales $ 13,269 $ 11,981 $ 31,613 $ 24,350
Cost of sales:        
Total cost of sales 8,279 7,781 20,806 16,536
Gross profit 4,990 4,200 10,807 7,814
Operating expenses:        
Engineering and development 858 717 1,694 1,344
Selling, general and administrative 3,895 3,507 7,512 6,890
Total operating expenses 4,753 4,224 9,206 8,234
Operating income (loss) 237 (24) 1,601 (420)
Other income (expense):        
Foreign exchange loss (115) 176 (616) 159
Interest expense (62) (101) (126) (206)
Interest income 325 126 586 271
Other (expense) income, net 7 (16) 41 3
Total other (expense) income, net 155 185 (115) 227
Income (loss) before income taxes 392 161 1,486 (193)
Income tax expense 71 5 204 17
Net income (loss) 321 156 1,282 (210)
Net income (loss) attributable to common shareholders $ 302 $ 148 $ 1,205 $ (210)
Net income (loss) per common share - basic $ 0.07 $ 0.03 $ 0.28 $ (0.05)
Weighted average common shares outstanding - basic 4,391 4,274 4,342 4,237
Net income (loss) per common share - diluted $ 0.07 $ 0.03 $ 0.27 $ (0.05)
Weighted average common shares outstanding net income - diluted 4,462 4,285 4,395 4,237
Product        
Sales:        
Total sales $ 8,988 $ 8,217 $ 23,209 $ 16,937
Cost of sales:        
Total cost of sales 6,580 6,265 17,351 13,542
Service        
Sales:        
Total sales 4,281 3,764 8,404 7,413
Cost of sales:        
Total cost of sales $ 1,699 $ 1,516 $ 3,455 $ 2,994